Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Mirai Bio Appoints Kate Torchilin As Chief Executive Officer and President

PRIVATEAug 26, 2026about 5 hours ago

Position

Chief Scientific Officer

Company

Mirai Bio

Jagesh V. Shah
CambridgeBiotechnology

Description

Mirai Bio has named Kate Torchilin as Chief Executive Officer and President, while also appointing Jagesh V. Shah as Chief Scientific Officer. These leadership changes are expected to enhance Mirai's partner-driven model and scientific capabilities.

Company Information

Company

Mirai Bio

Location

Cambridge, Massachusetts, United States

About

Mirai Bio is an innovation delivery partner for companies developing next-generation nucleic acid medicines. The company combines proprietary in vivo data, machine learning, and modular LNP design to improve drug delivery mechanisms. Mirai accelerates programs and supports its partners with a faster, lower-risk approach to clinical development.

Don't miss Mirai Bio's next move

Get an email the moment Mirai Bio changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Mirai Bio's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Mirai Bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.